Company OverviewAdvaxis Inc.
Advaxis (NASDAQ: ADXS) is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins.
Speaker Bio Kenneth A. Berlin
President and CEO
Advaxis Inc.
President and CEO
Advaxis Inc.
CEO with nearly 30 years of diverse experience predominately in general management and business development. Background in both high-value diagnostics and therapeutics with management experience covering numerous areas including general management, sales and marketing, business development, and strategic planning.
